U.S. FDA approved first biosimilar to treat Multiple Sclerosis
On Aug. 24, 2023, the U.S. Food and Drug Administration approved Sandoz’s Tyruko (natalizumab-sztn), the first biosimilar to…
New landmark Nature study provided long-sought mechanistic link between EBV and Multiple Sclerosis
On Jan. 24, 2022, Atara Biotherapeutics, a leader in T-cell immunotherapy, announced that it had leveraged its novel…
NIH scientists discovered new B cell that tempers autoimmunity
On Dec. 2, 2021, researchers at the National Eye Institute (NEI) announced they had identified, isolated, and characterized…
FDA Approved Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity
On Jul. 29, 2021, BOTOX(R) Allergan, an AbbVie company, announced that the U.S. Food and Drug Administration (FDA)…
BioNTech published data on novel mRNA vaccine approach to treat autoimmune diseases in Science
On Jan. 7, 2021, BioNTech announced publication of preclinical data on its novel mRNA vaccine approach against autoimmune…
Genentech drug Ocrevus (ocrelizumab) was approved
On Mar. 28, 2017, Genentech drug Ocrevus (ocrelizumab) was approved by the U.S. Food and Drug Administration (FDA)…
University of British Columbia researchers discovered a genetic link to multiple sclerosis
On Jun. 1, 2016, scientists at the University of British Columbia and Vancouver Coastal Health announced proof that…
Governor Mary Fallin dedicated OMRF’s new 186,000 square foot research tower
On Apr. 21, 2011, Governor Mary Fallin dedicated the Oklahoma Medical Research Foundation’s (OMRF) new 186,000 s.f. research…
OMRF’s Multiple Sclerosis Center of Excellence opened its doors
On Mar. 15, 2011, the Oklahoma Medical Research Foundation’s Multiple Sclerosis Center of Excellence, led by Dr. Gabriel…
Sanofi-aventis acquired Genzyme for $21 billion
On Feb. 15, 2011, Sanofi-aventis announced it would acquired Genzyme for $74 a share in cash or $21.1…
UCSF researchers discovered that B cells orchestrate the inflammation of myelin that causes multiple sclerosis
In 2008, University of California, San Francisco (UCSF) researchers discovered that B cells orchestrate the inflammation of myelin…
Acorda Therapeutics announced its its initial public offering
On Feb. 10, 2006, Acorda Therapeutics announced an initial public offering of 5,500,000 shares of common stock at…
Research caused concern that hepatitis B vaccination might be linked with multiple sclerosis
In 1998, some research caused concern that hepatitis B vaccination might be linked with multiple sclerosis (MS), a…
Chiron’s Betaseron was approved as the first treatment for multiple sclerosis in 20 years
On Jul. 23, 1993, Chiron and Berlex Laboratories announced that the U.S. Food and Drug Administration (FDA) had…
FDA approved Betaseron, the first of several biotech products that have had a major impact on multiple sclerosis treatment
On Jul. 23, 1993, the U.S. Food and Drug Administration (FDA) approved Betaseron, the first of several biotechnology…
Biotechnology | Diagnostics | HIV | Life Science News | NIH | Therapeutics
The first AIDS patient seen at the NIH was admitted
On Jun. 16, 1981, Dr. Thomas Waldmann helped treat the first patient with AIDS. In 2016, the Food…